California State Teachers Retirement System (CalSTRS)
ALLO icon

California State Teachers Retirement System (CalSTRS)’s Allogene Therapeutics ALLO Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio ALLO Stock Details ALLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.3K Sell
8,324
-1,143
-12% -$2.29K ﹤0.01% 2435
2025
Q4 		$13K Buy
9,467
+51
+0.5% +$67 ﹤0.01% 2695
2025
Q3 		$11.7K Buy
9,416
+7
+0.1% +$8 ﹤0.01% 2772
2025
Q2 		$10.6K Hold
9,409
– – ﹤0.01% 2718
2025
Q1 		$13.7K Sell
9,409
-126,145
-93% -$238K ﹤0.01% 2663
2024
Q4 		$289K Buy
135,554
+7,685
+6% +$19K ﹤0.01% 2296
2024
Q3 		$358K Sell
127,869
-12,112
-9% -$32.3K ﹤0.01% 2254
2024
Q2 		$326K Buy
139,981
+32,151
+30% +$94.8K ﹤0.01% 2269
2024
Q1 		$482K Sell
107,830
-4,628
-4% -$19.3K ﹤0.01% 2175
2023
Q4 		$361K Buy
112,458
+16,994
+18% +$48.2K ﹤0.01% 2347
2023
Q3 		$303K Sell
95,464
-8,134
-8% -$35.6K ﹤0.01% 2416
2023
Q2 		$515K Sell
103,598
-2,044
-2% -$11.1K ﹤0.01% 2292
2023
Q1 		$522K Sell
105,642
-1,125
-1% -$7.21K ﹤0.01% 2290
2022
Q4 		$672K Buy
106,767
+1,159
+1% +$10.7K ﹤0.01% 2180
2022
Q3 		$1.14M Sell
105,608
-1,394
-1% -$18.9K ﹤0.01% 1808
2022
Q2 		$1.22M Buy
107,002
+11,559
+12% +$103K ﹤0.01% 1810
2022
Q1 		$869K Sell
95,443
-7,325
-7% -$76.3K ﹤0.01% 2119
2021
Q4 		$1.53M Buy
102,768
+2,368
+2% +$41.8K ﹤0.01% 1897
2021
Q3 		$2.58M Buy
100,400
+6,700
+7% +$159K ﹤0.01% 1580
2021
Q2 		$2.44M Buy
93,700
+12,401
+15% +$354K ﹤0.01% 1662
2021
Q1 		$2.87M Sell
81,299
-344
-0.4% -$11.6K ﹤0.01% 1526
2020
Q4 		$2.06M Buy
81,643
+6
+0% +$196 ﹤0.01% 1630
2020
Q3 		$3.08M Buy
81,637
+8,495
+12% +$320K ﹤0.01% 1247
2020
Q2 		$3.13M Buy
73,142
+14,557
+25% +$526K 0.01% 1202
2020
Q1 		$1.14M Sell
58,585
-345
-0.6% -$8.22K ﹤0.01% 1622
2019
Q4 		$1.53M Sell
58,930
-1,672
-3% -$46K ﹤0.01% 1717
2019
Q3 		$1.65M Buy
60,602
+882
+1% +$25.1K ﹤0.01% 1638
2019
Q2 		$1.6M Buy
59,720
+25,595
+75% +$713K ﹤0.01% 1686
2019
Q1 		$987K Sell
34,125
-4,590
-12% -$133K ﹤0.01% 1948
2018
Q4 		$1.04M Buy
+38,715
New +$1.03M ﹤0.01% 1879

Other funds holding ALLO

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS)'s ALLO Position: Q1 2026 in Review

California State Teachers Retirement System (CalSTRS) reduced its Allogene Therapeutics (ALLO) stake by 12% in Q1 2026, selling an estimated $2.29K and leaving 8,324 shares worth $20.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2435.

California State Teachers Retirement System (CalSTRS) first reported a position in ALLO in Q4 2018 and has held it in 30 quarters since. The position peaked at $3.13M in Q2 2020. 208 funds tracked by Wall St. Rank hold ALLO as of Q1 2026.

  • California State Teachers Retirement System (CalSTRS) held 8,324 shares of Allogene Therapeutics worth $20.3K as of Q1 2026.
  • California State Teachers Retirement System (CalSTRS) sold 1,143 Allogene Therapeutics shares in Q1 2026, an estimated $2.29K.
  • Allogene Therapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q1 2026, its #2435 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Allogene Therapeutics in Q4 2018 and has held it in 30 quarters since.
  • California State Teachers Retirement System (CalSTRS)'s Allogene Therapeutics position peaked at $3.13M in Q2 2020.
  • 208 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q1 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2026, filed 18 May 2026.